News

FILTER BY:
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Surveillance: Year of the stock-picker (Steven Ricchiuto starts at 16:20)Surveillance: Year of the stock-picker (Steven Ricchiuto starts at 16:20)
News

Surveillance: Year of the stock-picker (Steven Ricchiuto starts at 16:20)

February 4, 2022
Top healthcare picks: AVTR, DHR, TMO, ILMN, NSTGTop healthcare picks: AVTR, DHR, TMO, ILMN, NSTG
News

Top healthcare picks: AVTR, DHR, TMO, ILMN, NSTG

February 4, 2022
Inside Out: PayPal (PYPL) and Block (SQ)Inside Out: PayPal (PYPL) and Block (SQ)
News

Inside Out: PayPal (PYPL) and Block (SQ)

February 4, 2022
World stockpiles are low due to lack of investment and it's a dire situationWorld stockpiles are low due to lack of investment and it's a dire situation
News

World stockpiles are low due to lack of investment and it's a dire situation

February 3, 2022
Tesla’s gross margins and profitability are ahead of everyone, says Mizuho analystTesla’s gross margins and profitability are ahead of everyone, says Mizuho analyst
News

Tesla’s gross margins and profitability are ahead of everyone, says Mizuho analyst

January 31, 2022
Natural gas price ‘behaving as if it wants to rip higher’ strategist saysNatural gas price ‘behaving as if it wants to rip higher’ strategist says
News

Natural gas price ‘behaving as if it wants to rip higher’ strategist says

January 31, 2022
We believe there will be a massive rebound in fintech stocks, says Mizuho senior analystWe believe there will be a massive rebound in fintech stocks, says Mizuho senior analyst
News

We believe there will be a massive rebound in fintech stocks, says Mizuho senior analyst

January 31, 2022
SHOP, AVLR, CDAY: Company growth drivers that stand outSHOP, AVLR, CDAY: Company growth drivers that stand out
News

SHOP, AVLR, CDAY: Company growth drivers that stand out

January 28, 2022
Mizuho’s Vamil Divan’s top biotech pick: AbbvieMizuho’s Vamil Divan’s top biotech pick: Abbvie
News

Mizuho’s Vamil Divan’s top biotech pick: Abbvie

January 28, 2022
back-to-top-blue